Literature DB >> 15748401

Efficiency of short and long term antimicrobial therapy in transrectal ultrasound-guided prostate biopsies.

Leonardo Petteffi1, Gustavo P Toniazzo, Guilherme B Sander, Alberto C Stein, Walter J Koff.   

Abstract

OBJECTIVE: Prostate biopsy is a frequent diagnostic measure to detect prostatic conditions, including primarily prostate cancer. Its performance does not follow a pattern, mainly regarding preparation for the examination through antimicrobial prophylaxis. The aim of this study is to compare the efficiency of short and long term antimicrobial prophylaxis in transrectal ultrasound-guided prostate biopsies.
MATERIALS AND METHODS: A clinical study was conducted with a total of 140 patients submitted to prostate biopsy with transrectal ultrasonographic control. Patients were randomly separated in two groups: Group 1 receiving norfloxacin 400mg single dose before the procedure and Group 2 receiving norfloxacin 400mg initiating before the procedure and then bid up to 6 doses. Efficiency control was determined by the incidence of urinary tract infection (UTI) and complications in both groups after statistical analysis.
RESULTS: The incidence of minor complications in our study was 75%, consistent with data found in the literature. Among the patients with diagnosis of simple UTI, 23% belonged to Group 1 and 8% to Group 2 (p=0.08). Among the patients with complicated UTI, 37% belonged to Group 1 and none belonged to Group 2 (p=0.44).
CONCLUSIONS: Several advances made transrectal ultrasound-guided prostate biopsies a useful and safe diagnostic tool in the workup of urologic patients. There is no optimal prophylactic preparation to the performance of this procedure. Long term antimicrobial prophylaxis presents a trend toward lower incidence of infectious complications.

Entities:  

Year:  2002        PMID: 15748401

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  4 in total

1.  Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy.

Authors:  Pedro Recabal; Taehyoung Lee; Emily Vertosick; Michael Manasia; James Eastham; Karim Touijer; Susan K Seo; Massimiliano Spaliviero; Behfar Ehdaie
Journal:  World J Urol       Date:  2019-06-12       Impact factor: 4.226

2.  A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance.

Authors:  Michael Samarinas; Konstantinos Dimitropoulos; Ioannis Zachos; Stavros Gravas; Anastasios Karatzas; Vasileios Tzortzis
Journal:  World J Urol       Date:  2016-03-07       Impact factor: 4.226

3.  Cefixime versus prulifloxacin as a prophylactic treatment for prostate biopsy: a randomized study.

Authors:  Michael Samarinas; Konstantinos Skriapas; Iraklis Mitsogiannis; Stavros Gravas; Anastasios Karatzas; Vasileios Tzortzis
Journal:  Cent European J Urol       Date:  2020-10-10

4.  Oral antibiotics in trans-rectal prostate biopsy and its efficacy to reduce infectious complications: Systematic review.

Authors:  Mohand Deeb Yaghi; E O Kehinde
Journal:  Urol Ann       Date:  2015-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.